Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency

Qingmei Jia, Michael L. Freeman, Eric J. Yager, Ian Howard Mchardy, Leming Tong, Dee Ann Martinez-Guzman, Tammy Rickabaugh, Seungmin Hwang, Marcia A. Blackman, Ren Sun, Ting Ting Wu

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Human gammaherpesviruses, Epstein-Barr virus, and human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus are important pathogens associated with diseases, including lymphomas and other malignancies. Murine gammaherpesvirus 68 (MHV-68) is used as an experimental model system to study the host immune control of infection and explore novel vaccine strategies based on latency-deficient live viruses. We studied the properties and the potential of a recombinant MHV-68 (AC-RTA) in which the genes required for persistent infection were replaced by a constitutively expressed viral transcription activator, RTA, which dictates the virus to lytic replication. After intranasal infection of mice, replication of AC-RTA in the lung was attenuated, and no AC-RTA virus or viral DNA was detected in the isolated splenocytes, indicating a lack of latency in the spleen. Infection of the AC-RTA virus elicited both cellular immune responses and virus-specific IgG at a level comparable to that elicited by infection of the wild-type virus. Importantly, vaccination of AC-RTA was able to protect mice against subsequent challenge by the wild-type MHV-68. AC-RTA provides a vaccine strategy for preventing infection of human gammaherpesviruses. Furthermore, our results suggest that immunity to the major latent antigens is not required for protection.

Original languageEnglish (US)
Pages (from-to)2453-2465
Number of pages13
JournalJournal of Virology
Volume84
Issue number5
DOIs
StatePublished - Mar 2010

Fingerprint

Murid herpesvirus 4
Virus Latency
Immunity
immunity
Viruses
viruses
Human herpesvirus 8
Human Herpesvirus 8
Infection
infection
Vaccines
vaccines
Viral DNA
Human herpesvirus 4
Virus Diseases
Infection Control
Human Herpesvirus 4
Cellular Immunity
mice
splenocytes

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency. / Jia, Qingmei; Freeman, Michael L.; Yager, Eric J.; Mchardy, Ian Howard; Tong, Leming; Martinez-Guzman, Dee Ann; Rickabaugh, Tammy; Hwang, Seungmin; Blackman, Marcia A.; Sun, Ren; Wu, Ting Ting.

In: Journal of Virology, Vol. 84, No. 5, 03.2010, p. 2453-2465.

Research output: Contribution to journalArticle

Jia, Q, Freeman, ML, Yager, EJ, Mchardy, IH, Tong, L, Martinez-Guzman, DA, Rickabaugh, T, Hwang, S, Blackman, MA, Sun, R & Wu, TT 2010, 'Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency', Journal of Virology, vol. 84, no. 5, pp. 2453-2465. https://doi.org/10.1128/JVI.01543-09
Jia, Qingmei ; Freeman, Michael L. ; Yager, Eric J. ; Mchardy, Ian Howard ; Tong, Leming ; Martinez-Guzman, Dee Ann ; Rickabaugh, Tammy ; Hwang, Seungmin ; Blackman, Marcia A. ; Sun, Ren ; Wu, Ting Ting. / Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency. In: Journal of Virology. 2010 ; Vol. 84, No. 5. pp. 2453-2465.
@article{1c094b82947a493396f1b3cba9526baf,
title = "Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency",
abstract = "Human gammaherpesviruses, Epstein-Barr virus, and human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus are important pathogens associated with diseases, including lymphomas and other malignancies. Murine gammaherpesvirus 68 (MHV-68) is used as an experimental model system to study the host immune control of infection and explore novel vaccine strategies based on latency-deficient live viruses. We studied the properties and the potential of a recombinant MHV-68 (AC-RTA) in which the genes required for persistent infection were replaced by a constitutively expressed viral transcription activator, RTA, which dictates the virus to lytic replication. After intranasal infection of mice, replication of AC-RTA in the lung was attenuated, and no AC-RTA virus or viral DNA was detected in the isolated splenocytes, indicating a lack of latency in the spleen. Infection of the AC-RTA virus elicited both cellular immune responses and virus-specific IgG at a level comparable to that elicited by infection of the wild-type virus. Importantly, vaccination of AC-RTA was able to protect mice against subsequent challenge by the wild-type MHV-68. AC-RTA provides a vaccine strategy for preventing infection of human gammaherpesviruses. Furthermore, our results suggest that immunity to the major latent antigens is not required for protection.",
author = "Qingmei Jia and Freeman, {Michael L.} and Yager, {Eric J.} and Mchardy, {Ian Howard} and Leming Tong and Martinez-Guzman, {Dee Ann} and Tammy Rickabaugh and Seungmin Hwang and Blackman, {Marcia A.} and Ren Sun and Wu, {Ting Ting}",
year = "2010",
month = "3",
doi = "10.1128/JVI.01543-09",
language = "English (US)",
volume = "84",
pages = "2453--2465",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency

AU - Jia, Qingmei

AU - Freeman, Michael L.

AU - Yager, Eric J.

AU - Mchardy, Ian Howard

AU - Tong, Leming

AU - Martinez-Guzman, Dee Ann

AU - Rickabaugh, Tammy

AU - Hwang, Seungmin

AU - Blackman, Marcia A.

AU - Sun, Ren

AU - Wu, Ting Ting

PY - 2010/3

Y1 - 2010/3

N2 - Human gammaherpesviruses, Epstein-Barr virus, and human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus are important pathogens associated with diseases, including lymphomas and other malignancies. Murine gammaherpesvirus 68 (MHV-68) is used as an experimental model system to study the host immune control of infection and explore novel vaccine strategies based on latency-deficient live viruses. We studied the properties and the potential of a recombinant MHV-68 (AC-RTA) in which the genes required for persistent infection were replaced by a constitutively expressed viral transcription activator, RTA, which dictates the virus to lytic replication. After intranasal infection of mice, replication of AC-RTA in the lung was attenuated, and no AC-RTA virus or viral DNA was detected in the isolated splenocytes, indicating a lack of latency in the spleen. Infection of the AC-RTA virus elicited both cellular immune responses and virus-specific IgG at a level comparable to that elicited by infection of the wild-type virus. Importantly, vaccination of AC-RTA was able to protect mice against subsequent challenge by the wild-type MHV-68. AC-RTA provides a vaccine strategy for preventing infection of human gammaherpesviruses. Furthermore, our results suggest that immunity to the major latent antigens is not required for protection.

AB - Human gammaherpesviruses, Epstein-Barr virus, and human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus are important pathogens associated with diseases, including lymphomas and other malignancies. Murine gammaherpesvirus 68 (MHV-68) is used as an experimental model system to study the host immune control of infection and explore novel vaccine strategies based on latency-deficient live viruses. We studied the properties and the potential of a recombinant MHV-68 (AC-RTA) in which the genes required for persistent infection were replaced by a constitutively expressed viral transcription activator, RTA, which dictates the virus to lytic replication. After intranasal infection of mice, replication of AC-RTA in the lung was attenuated, and no AC-RTA virus or viral DNA was detected in the isolated splenocytes, indicating a lack of latency in the spleen. Infection of the AC-RTA virus elicited both cellular immune responses and virus-specific IgG at a level comparable to that elicited by infection of the wild-type virus. Importantly, vaccination of AC-RTA was able to protect mice against subsequent challenge by the wild-type MHV-68. AC-RTA provides a vaccine strategy for preventing infection of human gammaherpesviruses. Furthermore, our results suggest that immunity to the major latent antigens is not required for protection.

UR - http://www.scopus.com/inward/record.url?scp=77649219630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649219630&partnerID=8YFLogxK

U2 - 10.1128/JVI.01543-09

DO - 10.1128/JVI.01543-09

M3 - Article

C2 - 20015983

AN - SCOPUS:77649219630

VL - 84

SP - 2453

EP - 2465

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 5

ER -